In this article, we will take a look at the aggressive stock portfolio: 5 stocks picked by analysts. To read our analysis of the recent market activity, you can go to the Aggressive Stock Portfolio: 13 Stocks Picked by Analysts.
5. BlackBerry Limited (NYSE:BB)
Average Analyst Price Target as of March 28: $4.54
Upside Potential as of March 28: 64.49%
Number of Hedge Fund Holders: 15
Ontario, Canada-based BlackBerry Limited (NYSE:BB) is a leader in cybersecurity. Its products and services include AI-based endpoint security solutions, unified endpoint management platform, critical event management solution, and software for secure embedded systems.
On February 12, BlackBerry Limited (NYSE:BB) provided an update on its efforts to drive the company towards profitability and positive cash flow. The company is targeting $100 million of annualized net profit improvements, through a combination of cost reductions and margin expansion.
Like other stocks such as Gogo Inc. (NASDAQ:GOGO), Telephone & Data Systems, Inc. (NYSE:TDS), and Custom Truck One Source, Inc. (NYSE:CTOS), BlackBerry Limited (NYSE:BB) is among the aggressive stock portfolio: 13 stocks picked by analysts.
4. Telephone & Data Systems, Inc. (NYSE:TDS)
Average Analyst Price Target as of March 28: $26.67
Upside Potential as of March 28: 66.48%
Number of Hedge Fund Holders: 28
Telephone & Data Systems, Inc. (NYSE:TDS) is a diversified telecommunications company that provides wireless products and services; cable and wireline broadband, video and voice services; and hosted and managed services to approximately 6 million customers in the US.
On February 16, Telephone & Data Systems, Inc. (NYSE:TDS) released its financial results for Q4 2023 with operating revenues of $1.3 billion and a net loss of $523 million.
As of Q4 2023, Telephone & Data Systems, Inc. (NYSE:TDS) shares were owned by 28 hedge funds tracked by Insider Monkey, the second highest on our list of aggressive stock portfolio: 13 stocks picked by analysts. Dan Loeb’s Third Point was its lead hedge fund shareholder with ownership of 2.1 million shares valued at $39 million.
3. NovoCure Limited (NASDAQ:NVCR)
Average Analyst Price Target as of March 28: $26.43
Upside Potential as of March 28: 69.10%
Number of Hedge Fund Holders: 29
Root, Switzerland-based NovoCure Limited (NASDAQ:NVCR) is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor Treating Fields.
The portfolio of NovoCure Limited (NASDAQ:NVCR) includes products approved in certain countries for the treatment of adult patients with glioblastoma, malignant pleural mesothelioma, and pleural mesothelioma. Its clinical trials pipeline includes Tumor Treating Fields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer.
NovoCure Limited (NASDAQ:NVCR) is expecting top-line data from the phase 3 METIS clinical trial in brain metastases by the end of Q1 2024. Earlier in January, the FDA accepted the Premarket Approval (PMA) application seeking approval for the use of TTFields therapy together with standard therapies for the treatment of NSCLC.
2. Archer Aviation Inc. (NYSE:ACHR)
Average Analyst Price Target as of March 28: $9.83
Upside Potential as of March 28: 112.77%
Number of Hedge Fund Holders: 22
Santa Clara, California-based Archer Aviation Inc. (NYSE:ACHR) is designing and developing electric vertical takeoff and landing aircraft for use in urban air mobility networks.
On March 11, Archer Aviation Inc. (NYSE:ACHR) announced a partnership with Falcon Aviation, a prominent Aviation Services Operator in the UAE, as their vertiport infrastructure partner for critical locations in Dubai and Abu Dhabi. Last year, the companies had signed a collaboration agreement under which Falcon Aviation was to operate a fleet of Archer’s Midnight electric aircraft and expand the two companies’ urban air mobility ecosystem in the UAE.
On February 27, Cantor Fitzgerald analyst Andres Sheppard maintained an ‘Overweight’ rating for Archer Aviation Inc. (NYSE:ACHR) shares with a price target of $10 per share which represents a potential upside of 99.20%.
1. Enovix Corporation (NASDAQ:ENVX)
Average Analyst Price Target as of March 28: $28.75
Upside Potential as of March 28: 258.93%
Number of Hedge Fund Holders: 25
Sao Paulo, Brazil-based Enovix Corporation (NASDAQ:ENVX) is an advanced silicon battery company with a disruptive architecture that enables a battery with high energy density. The company is scaling its silicon-anode, lithium-ion battery manufacturing capabilities to meet customer demand.
During Q4 2023, Enovix Corporation (NASDAQ:ENVX) completed the acquisition of Routejade, an established Korean battery manufacturer. The company also built out approximately 250,000 square feet of factory space and began receiving shipments of Gen2 equipment that had cleared Factory Acceptance Testing. It remains on track to produce first silicon battery samples from Fab2 in April.
As of Q4 2023, 25 prominent hedge funds tracked by Insider Monkey held shares of Enovix Corporation (NASDAQ:ENVX), valued at $173 million. John Shaver’s Electron Capital Partners was the lead hedge fund shareholder with ownership of 3.2 million shares valued at $41 million.
You may also like to read 11 Best Agriculture ETFs To Buy and 10 Best Long Term ASX Stocks To Invest In
Hedge Fund Resource Center